Hot Pursuit     07-Apr-22
Biocon Ltd soars 0.56%, rises for fifth straight session
Biocon Ltd is quoting at Rs 352.25, up 0.56% on the day as on 12:49 IST on the NSE. The stock is down 14.76% in last one year as compared to a 19.38% spurt in NIFTY and a 9.61% spurt in the Nifty Pharma.

Biocon Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 352.25, up 0.56% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.29% on the day, quoting at 17756.25. The Sensex is at 59387.21, down 0.37%. Biocon Ltd has risen around 5.32% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has risen around 7.62% in last one month and is currently quoting at 13758.45, up 0.48% on the day. The volume in the stock stood at 29.01 lakh shares today, compared to the daily average of 28.37 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 353, up 0.53% on the day. Biocon Ltd is down 14.76% in last one year as compared to a 19.38% spurt in NIFTY and a 9.61% spurt in the Nifty Pharma index.

The PE of the stock is 364.69 based on TTM earnings ending December 21.

Previous News
  Biocon Biologics receives UDFDA approval for Yesafili™
 ( Corporate News - 21-May-24   09:13 )
  Biocon reports consolidated net profit of Rs 660.00 crore in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:41 )
  Biocon CFO resigns
 ( Corporate News - 08-Feb-24   19:43 )
  Biocon Ltd soars 1.22%, rises for fifth straight session
 ( Hot Pursuit - 27-Mar-24   13:00 )
  Biocon Ltd up for fifth session
 ( Hot Pursuit - 06-Feb-24   13:00 )
  Biocon
 ( Results - Analysis 17-May-24   10:41 )
  Biocon announces resignation of senior management
 ( Corporate News - 08-Feb-24   19:49 )
  Biocon gains after arm inks distribution agreement with Sandoz
 ( Hot Pursuit - 26-Dec-23   10:40 )
  Biocon records PAT of Rs 101 crore in Q1; EBITDA margin at 23%
 ( Hot Pursuit - 11-Aug-23   11:13 )
  Biocon 's biologics subsidiary gets European Commission's nod for Aflibercept biosimilar
 ( Hot Pursuit - 21-Sep-23   09:24 )
  USFDA classifies inspection of Biocon Biologic's Malaysian unit as 'OAI'
 ( Corporate News - 18-Oct-23   09:28 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top